Hyperkalaemia in cyclosporin-treated renal allograft recipients

Lancet (London, England)
|August 13, 1983
PubMed

Insights

Cyclosporine treatment in kidney transplant patients can lead to sustained hyperkalemia and acidosis. This is often caused by impaired aldosterone and renin function, worsened by beta-blockers.

Area of Science:

  • Nephrology
  • Immunosuppression Pharmacology

Background:

  • Cyclosporine is a common immunosuppressant after renal transplantation.
  • Hyperkalemia is a potential side effect of immunosuppressive therapy.

Purpose of the Study:

  • To investigate the causes of sustained hyperkalemia in renal allograft recipients treated with cyclosporine.
  • To identify factors contributing to hyperkalemia and associated metabolic acidosis.

Main Methods:

  • Compared serum potassium levels in cyclosporine recipients versus prednisolone and azathioprine recipients.
  • Analyzed renal function, acid-base status, and hormonal levels (aldosterone, renin) in hyperkalemic patients.
  • Assessed urine pH and the impact of beta-blockers and nephrectomy.

Main Results:

  • Significantly higher mean serum potassium levels observed in cyclosporine group for 9 months.
  • Seven of 43 cyclosporine patients developed sustained hyperkalemia (6.0-7.1 mmol/l) with hyperchloremic acidosis.
  • Hypoaldosteronism, renal tubular defects, and hyporeninemia (potentially due to beta-blockers) were implicated in hyperkalemic patients.

Conclusions:

  • Cyclosporine-induced hyperkalemia in renal transplant recipients is linked to impaired potassium and hydrogen ion secretion.
  • Hyporeninemia and hypoaldosteronism, potentially exacerbated by beta-blockers, contribute to this condition.

Related Concept Videos

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...